1. Erica Brown, PhD Director, NIH Guide to Grants and Contracts Office of Extramural Research National Institutes of Health May 2015

2. Funding Opportunity Announcement Fundamentals 2

3. Overview A publicly available document by which a Federal Agency makes known its intentions to award discretionary grants or cooperative agreements Organization and content of FOA is defined by the Office of Management and Budget (OMB) Published in the NIH Guide to Grants and Contracts and Grants.gov

4. Types of FOA Requests for Applications (RFAs) ▫ Solicit applications in a well-defined scientific area to accomplish specific program objectives ▫ Indicate the amount of set-aside funds and anticipated number of awards Program Announcements (PAs) ▫ Encourages applications for a new or ongoing extramural activity or program ▫ Formerly termed “unsolicited” applications ▫ PAS - PA with set-aside funds ▫ PAR - PA with special receipt, referral and/or review considerations

5. Parent Announcements NIH-wide FOA enabling applicants to submit an investigator-initiated application for a specific activity code Some ICs may not participate in all parent announcements. ▫ Check the FOA View Contacts and Special Interests websites for each Parent Announcement for IC-specific information List of all Parent Announcements: Parent Announcements for Unsolicited or Investigator- Initiated ApplicationsParent Announcements for Unsolicited or Investigator- Initiated Applications 5

6. Types of Notices Policy NoticeAnnounces a new policy Notice of Change to Funding Opportunity Modifies an existing FOA Notice of Intent to Publish (NOITP) Alerts the community about an upcoming FOA Notice of InformationAny notice other than the above types (i.e., announcements of FAQs, pre-application webinars) Request for Information (RFI)Requests comments from the extramural community on a particular issue Request for Proposals (RFP)Announces a request for proposals for a contract award

7. Restrictions on Timeframe between Publication and First Due Date AnnouncementDays RFAs60 New PA, PAR, or PAS60 Reissuance of active PA, PAR, or PAS30 Notice of Change to PA, PAR, or PAS30 Notice of Change to RFA60

8. Finding Funding Opportunity Announcements 8

9. Grants.gov 9

10. 10

11. NIH Guide for Grants and Contracts 11

12. 12

13. 13

14. Finding FOAs and Notices Grants.gov ▫ FOAs NIH Guide to Grants and Contracts ▫ FOAs ▫ Notice 2014 by the numbers… ▫ FOAs: 703 ▫ Notices: 705 14

15. Understanding Funding Opportunity Announcements 15

16. FOA Table of Contents Part 1. Overview Information Key Dates Part 2. Full Text of the Announcement Section I. Funding Opportunity Description Section II. Award Information Section III. Eligibility Information Section IV. Application and Submission Information Section V. Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII. Other Information

17. Part 1. Overview Information 17 Participating Organization(s) National Institutes of Health (NIH)NIH Components of Participating Organizations National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Mental Health (NIMH)NIAIDNIMH Funding Opportunity Title Innovative Measures of Oral Medication Adherence for HIV Treatment and Prevention (R01) Activity Code R01R01 Research Project Grant Announcement Type New Related Notices January 29, 2015 - Notice of Clarification of Funds Available and Anticipated Number of Awards for RFA-AI-14-071. See Notice NOT-AI-15-018 NOT-AI-15-018 Funding Opportunity Announcement (FOA) Number RFA-AI-14-071 Companion Funding Opportunity None Number of Applications See Section III. 3. Additional Information on Eligibility.Section III. 3. Additional Information on Eligibility Catalog of Federal Domestic Assistance (CFDA) Number(s) 93.855; 93.856; 93.242 Funding Opportunity Purpose The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative research applications that seek to advance the development of bioanalytical assays, pill ingestion sensors, drug metabolite and taggant detection systems, or wireless technologic approaches for monitoring and improving adherence to oral antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP).

18. What differentiates activity codes? Goal Award Budget Project Period Institutional Eligibility PD/PI Eligibility 18

19. Part 1. Key Dates 19 Posted Date November 26, 2014 Open Date (Earliest Submission Date) February 25, 2015 Letter of Intent Due Date(s) February 25, 2015 Application Due Date(s) March 25, 2015, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.types of non-AIDS applications Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. AIDS Application Due Date(s) March 25, 2015, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on this date.types of AIDS and AIDS-related applications Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Scientific Merit Review July 2015 Advisory Council Review October 2015 Earliest Start Date December 2015 Expiration Date March 26, 2015 Due Dates for E.O. 12372 Not Applicable

20. FOA ‘Glossary’ Understanding options and requirements ▫ Encouraged ▫ Expected ▫ Should ▫ Must and Required Requirements for successful submission ▫ Responsiveness: Section I – Scope  Only applicable to RFAs ▫ Compliance: Section II – Budget, Project Period ▫ Eligibility: Section III – Institution, PD/PI, Number of applications ▫ Completeness: Section IV – Application Instructions 20

21. Part 2. Section I Funding Opportunity Description Purpose: Goals of the funding opportunity Background: Relevant background information and the importance of the funding opportunity Research Objectives: Description of specific areas of research interest; examples of targeted research topics and/or and experimental approaches that are being sought to achieve the objectives.

22. Understanding Responsiveness Specific Areas of Research Interest This FOA will support the development of assays, devices, or monitoring tools and clinical studies to validate their use in measuring ARV adherence. Early-stage clinical trials designed to examine feasibility, acceptability, and the preliminary impact on ARV adherence can also be supported. Applicants are encouraged to test feasibility and acceptability in populations known to be challenged by adherence, such as those with mental health disorders or adolescents. Clinical populations in the United States or international settings may be appropriate for research proposed under this FOA. Examples of projects of interest under this FOA include: Development and validation of ARV metabolite assays in clinical specimens followed by feasibility and acceptability testing in a clinic population. Development and validation of medication taggants followed by feasibility and acceptability testing in a clinic population. Prospective studies that test feasibility and acceptability of ARV adherence monitoring approaches that provide confirmation of oral medication ingestion through ingestion sensors or other metabolite detection systems………

23. Understanding Responsiveness Non-responsive Areas of Research Applications proposing any of the following research topics will be identified as non- responsive and will not be reviewed. Clinical trials designed to test efficacy or effectiveness in improving adherence behavior Research focusing exclusively on self-reported measures of adherence (via questionnaires, text messages, etc.). Electronic drug monitoring devices that lack wireless capacities. Use of assays that involve invasive specimen collection (e.g., tissue biopsies, collection of cerebrospinal fluid) that would impact acceptability to patients. Studies focusing exclusively on clinic- or home-based pill count approaches to adherence assessment. Applicants are strongly encouraged to contact the Scientific/Research Contact(s), listed in Section VII of this FOA, to discuss the appropriateness of the scope of the proposed project.

24. Part 2. Section 2 Award Information 24 Funding Instrument Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed New The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.OER Glossary Funds Available and Anticipated Number of Awards Issuing IC and partner component intend to commit an estimated total of $7 million to fund 6-8 awards.component Award Budget Application budgets are not limited but need to reflect the actual needs of the proposed project. Award Project Period The scope of the proposed project should determine the project period. The project period can be 3-5 years.

25. Understanding Compliance May an applicant submit a Resubmission application to this FOA? May an applicant submit an application with a budget of $400,000 in direct costs per year for a total of 5 years? 25

26. Part 2. Section 3 Eligibility Information Eligible institutions ▫ Application is submitted by institution ▫ Eligibility of foreign institutions is most variable eligibility issue Eligible individuals ▫ Only applicable for PD/PI ▫ Multiple PD/PI applications: Eligibility requirements apply to all PD/PIs Number of applications ▫ Usually only limited to avoid duplicate or highly overlapping applications

27. Understanding Eligibility Is an application proposing multiple PDs/PIs eligible for this FOA? 27 Eligible Individuals (Program Director/Principal Investigator) Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

28. Part 2. Section IV Application and Submission Information Letters of Intent ▫ Requested in some FOAs to help with planning the review ▫ Not required; does not impact review

29. Instructions for Application Submission ▫ Instructs applicant to follow instructions in the SF 424 (R&R) Application Guide ▫ Lists of all the forms available in the application package with additional FOA-specific instructions ▫ An applicant should be able to prepare an application by reading the SF424 (R&R) Application Guide and this section only Part 2. Section IV Application and Submission Information

30. Understanding Completeness PHS 398 Research Plan All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Research Strategy: As part of the Research Strategy, applicants should clearly describe how the assay, device, or tool for monitoring ARV adherence will address all or most of the following characteristics: Indicate that oral medication ingestion occurred; Offer real-time monitoring of adherence behavior in ecological settings; Allow for discernment of longitudinal patterns of adherence; and Provide timely feedback on adherence patterns so that HIV preventative and therapeutic outcomes can be optimized. Applicants must include a Management Plan with milestones and timelines. This plan should outline any pre-clinical development of the bioanalytical adherence assay or monitoring tool, if applicable…..

31. Understanding Completeness Is an application complete if the Research Strategy does not describe one of the characteristics outlined in the FOA? Is an application complete if the Research Strategy does not include a Management Plan? Is an application complete if the Research Strategy includes a Management Plan with milestones and timelines that are not reasonable?

32. Part 2. Section V Application Review Information Review criteria ▫ Standard review criteria used to evaluate scientific and technical merit ▫ Only PARs and RFAs may have non-standard review criteria ▫ Each additional review question must map to an expectation that has been explained to applicants earlier in the FOA Review and selection process ▫ Minimal information about peer review process ▫ Considerations for funding decisions

33. Part 2. Section VI Award Administration Information Award Notices ▫ FOA-specific provisions to be included in Notice of Award Cooperative Agreement Terms and Conditions of Award (only for U activity codes) Reporting requirements 33

34. Part 2. Section VII Agency Contacts Application Submission Contacts ▫ eRA Commons Help Desk: eRA Commons registration, submitting and tracking an application, documenting system problems that threaten submission by the due date, post submission issues ▫ Grants.gov Customer Support: Grants.gov registration and submission, downloading forms and application packages ▫ GrantsInfo: application instructions and process, finding NIH grant resources 34

35. Part 2. Section VII Agency Contacts IC-specific contacts ▫ Scientific/Research ▫ Peer Review ▫ Financial/Grants Management 35

36. Questions? 36